PROVEN WITH 18+ YEARS OF CLINICAL UTILITY
MENTIONED BY NAME AND USED TO ESTABLISH THE IMWG GUIDELINES
REFERENCED IN >3,000 PUBLICATIONS
© Copyright 2020 Binding Site, INC

The NCCN and IMWG guidelines recommend SPE, IFE, and serum free light chain (sFLC) testing in the initial diagnostic workup for patients suspected of having Multiple Myeloma.(1,2) 

SPE + IFE + Freelite® tests = Guideline Compliant Testing

Get your FREE copy of the IMWG guidelines below.

Get your FREE copy of the IMWG guidelines below.

Are you following the Guidelines? 

Freelite is a registered trademark of The Binding Site Group Ltd (Birmingham, UK) in certain countries.

(800) 633-4484

SPE + IFE + sFLC = Guideline Compliant Testing

The NCCN and IMWG guidelines recommend SPE, IFE, and serum free light chain (sFLC) testing in the initial diagnostic workup for patients suspected of having Multiple Myeloma.(1,2) 

Only Freelite®  tests by Binding Site are

1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Multiple Myeloma V.1.2018 © National Comprehensive Cancer Network, Inc. 2018. All rights reserved. Accessed  Feb 20, 2020. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or ap-plication and disclaims any responsibility for their application or use in any way.

2. Dispenzieri A, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23:215-224

References: